HOME >> MEDICINE >> NEWS
Trial stops after stroke and mortality significantly reduced by blood

An international trial looking at the benefits of giving blood-pressure lowering medication to elderly patients has stopped early, after researchers observed significant reductions in overall mortality in those receiving treatment.

An international trial looking at the benefits of giving blood-pressure lowering medication to elderly patients has stopped early, after researchers observed significant reductions in overall mortality in those receiving treatment.

The 3,845 patient Hypertension in the Very Elderly Trial (HYVET) is the largest ever clinical trial to look at the effects of lowering blood pressure solely in those aged 80 and over. Preliminary results of the trial, which is coordinated by scientists from Imperial College London, suggest that lowering blood pressure significantly reduces both stroke and mortality in the over-80s.

A number of earlier trials had demonstrated that reducing blood pressure in the under-80s reduces stroke and cardiovascular events. However, previous smaller and inconclusive studies also suggested that whilst lowering blood pressure in those aged 80 or over reduced the number of strokes, it did not reduce, and even increased, total mortality.

Patients with high blood pressure from across the world were randomised for the double-blind, placebo-controlled trial, which began in 2001. Patients were given either the placebo or a low dose diuretic (indapamide 1.5mg SR), and an additional ACE inhibitor (perindopril), in tablet form once a day.

Emeritus Professor Chris Bulpitt, HYVET Principal Investigator from the Care of the Elderly Department at Imperial College London, said: "It was not clear prior to our study whether the over-80s would benefit from blood pressure lowering medication in the same way as younger people. Our results are great news for people in this age group because they suggest that where they have high blood pressure, such
'"/>

Contact: Laura Gallagher
L.Gallagher@imperial.ac.uk
44-020-759-46702
Imperial College London
6-Aug-2007


Page: 1 2

Related medicine news :

1. Trials underway for essential new TB vaccine
2. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
3. ENDEAVOR III Trial reports key findings on new-generation stent
4. NIH names Clinical Trial Units for the Microbicide Trials Network
5. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
6. The Public Library of Science launches the new open access journal PLoS Clinical Trials
7. Trial shows vaccine against cervical cancer provides long-term protection
8. Trial shows malaria vaccine could protect young children from disease for 18 months
9. Trial demonstrates new drugs effectiveness against psoriasis
10. Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
11. Second implant of US Pilot Trial achieved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... VALLEY, Minn. (PRWEB) , ... September 11, 2019 ... ... (MACKIS) conference will be held September 11-14 in Minneapolis at the Mall of ... Dr. Robert LaPrade, will be faculty members for the high-profile, knee-focused conference, which ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... Autopsies don’t ... damage or injury to the body. , Methamphetamine permanently harms the heart. It ... doctors are getting a better understanding of how the damage occurs. , ...
(Date:9/11/2019)... ... September 11, 2019 , ... Executives at health systems and hospitals across America ... industry over the past several years has been intense. For professionals and organizations that ... in America will depend largely on how these executives respond. Will they have the ...
(Date:9/11/2019)... ... September 10, 2019 , ... Four Shriners for Children Medical ... been recognized among the best doctors in the San Gabriel Valley for providing ... Robert H. Cho, M.D. – Chief of Staff, scoliosis, spinal deformity surgery, limb ...
(Date:9/11/2019)... ... September 11, 2019 , ... Dimensional Insight®, a data ... at the annual St. Jude Walk/Run Boston. To be held on Saturday, Sept. 28 ... raise a goal of $650,000 for St. Jude Children’s Research Hospital®. , ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... ... 11, 2019 , ... Abilene Christian University (ACU) is offering an alternative entry ... online BSN to DNP program pathway is meant to serve as a fast track ... degree to a Doctor of Nursing Practice degree. , Traditionally, a student would ...
(Date:9/11/2019)... ... September 11, 2019 , ... LifePod® ... innovator HomeThrive has selected LifePod’s voice-first service for rollout to an initial 100 ... over the age of 50, demand has steadily increased for solutions that both ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed Genedata ... system, and other medical indications. , “As part of our strategy to ...
Breaking Medicine Technology:
Cached News: